Association of health-related quality of life (HRQOL) variations with biological biomarkers for patients with metastatic castrate-resistant prostate cancer (MCRPC) treated by abiraterone/prednisone combination or prednisone.

Affiliation auteurs!!!! Error affiliation !!!!
TitreAssociation of health-related quality of life (HRQOL) variations with biological biomarkers for patients with metastatic castrate-resistant prostate cancer (MCRPC) treated by abiraterone/prednisone combination or prednisone.
Type de publicationJournal Article
Year of Publication2021
AuteursGoujon M, Anota A, Charton FAlexandre, Charton E, Maurina T, Almotlak H, Nguyen T, Fabien C, Stein U, Mouillet G, Thiery-Vuillemin A
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume39
Date PublishedFEB 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2021.39.6_suppl.54